Abstract
Purpose
The purpose of the study is to investigate whether analysis of specific antibody synthesis can aid the diagnosis of herpes keratitis.
Methods
Aqueous humor was collected from 39 patients with presumed recurrent herpes keratitis, including 23 consulting for keratitis and 16 patients scheduled for penetrating keratoplasty. Local antibody production was ascertained by analysis of paired aqueous humor/serum samples, using a modified micro-ELISA technique.
Results
Local production of antibodies was found in 32 patients (82%): anti-herpes simplex virus (HSV) antibodies in 26 (67%) and anti-varicella zoster virus (VZV) antibodies in 11 (28%). Twenty of 23 patients with active keratitis (87%), and 12 of 16 undergoing keratoplasty (75%), tested positive. Five patients had local production of both anti-HSV and anti-VZV antibodies, whereas seven patients tested negative. Local antibody production was significantly associated with intraocular inflammation (P<0.05), corneal neovascularisation (P<0.05), and positive response to anti-viral treatment (P<0.05). No complications were encountered in sampling aqueous humor.
Conclusions
Assessment of local anti-HSV and -VZV antibody production is a safe and reliable diagnostic procedure for recurrent herpes keratitis. It might be particularly helpful in patients presenting with intraocular inflammation and neovascularisation since it discriminates between herpes and non-herpes pathologies and may therefore be useful for preventive and therapeutic strategies.
Similar content being viewed by others
References
Baron A, Desmond G (1959) L'examen sérologique de l'humeur aqueuse au cours des uvéites. Bull Soc Ophtalmol Fr 59:793–796
Biswas S, Suresh P, Bonshek RE, Corbitt G, Tullo AB, Ridgway AE (2000) Graft failure in human donor corneas due to transmission of herpes simplex virus. Br J Ophthalmol 84:701–705
Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234–235
Borderie VM, Meritet JF, Chaumeil C, Rozenberg F, Baudrimont M, Touzeau O, Bourcier T, Laroche L (2004) Culture-proven herpetic keratitis after penetrating keratoplasty in patients with no previous history of herpes disease. Cornea 23:118–124
Cantin EM, Chen J, McNeill J, Willey DE, Openshaw H (1991) Detection of herpes simplex virus DNA sequences in corneal transplant recipients by polymerase chain reaction assays. Curr Eye Res 10:15–21
Davis JL, Feuer W, Culbertson WW, Pflugfelder SC (1995) Interpretation of intraocular and serum antibody levels in necrotizing retinitis. Retina 15:233–240
Dussaix E, Cerqueti PM, Pontet F (1987) New approaches to the detection of locally produced antiviral antibodies in the aqueous of patients with endogenous uveitis. Ophthalmologica 194:145–149
Easton HG (1970) Zoster sine herpete causing acute trigeminal neuralgia. Lancet 2:1065–1066
Felgenhauer K (1982) Differentiation of the humoral immune response in inflammatory diseases of the central nervous system. J Neurol 228:223–247
Goldman H, Witmer R (1954) Antikörper im Kammerwasser. Ophthalmologica 127:323–330
Group HEDS (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 339:300–306
Hartmann C, Felgenhauer K, Hanssen C (1983) Filtration und lokale Synthese von Proteinen im Kammerwasser und Liquor Cerebrospinalis. Fortschr Ophthalmol 80:103–107
Kaye SB, Lynas C, Patterson A, Risk JM, McCarthy K, Hart CA (1991) Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol 75:195–200
Kijlstra A, Onkosuwito J, Wienesenvan Doom M (1997) Serological and PCR analysis of ocular fluids is an important tool in the diagnostic workup of a uveitis patient presenting as a diagnostic dilemma. Ophthalmic Res 30:98
Lairson DR, Begley CE, Reynolds TF, Wilhelmus KR (2003) Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch Ophthalmol 121:108–112
Lausch RN, Monteiro C, Kleinschradt WR, Oakes JE (1987) Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye. Investig Ophthalmol Vis Sci 28:565–570
Liekfeld A, Jaeckel C, Pleyer U, Robert PY, Hartmann C (2001) Kammerwasseranalyse in Keratoplastikpatienten mit Keratitiden. Erste Resultate. Ophthalmologie 98:456–459
Liekfeld A, Schweig F, Jaeckel C, Wernecke KD, Hartmann C, Pleyer U (2000) Intraocular antibody production in intraocular inflammation. Graefe Arch Clin Exp Ophthalmol 238:222–227
Metcalf J, Koga J, Chatterjee S, Whitley RW (1987) Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease. Curr Eye Res 6:173
Meyers-Elliott RH, Pettit TH, Maxwell WA (1980) Viral antigens in the immune ring of Herpes simplex stromal keratitis. Arch Ophthalmol 98:897–904
Pavan-Langston D, Dunkel E (1996) Varicella-zoster virus diseases: anterior segment of the eye. In: JS Pepose, GN Holland, KR Wilhelmus (eds) Ocular infection and immunity. Mosby, St Louis, pp 933–957
Quentin CD, Reiber H (2004) Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 138:46–54
Rezende RA, Uchoa UB, Raber IM, Rapuano CJ, Laibson PR, Cohen EJ (2004) New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol 137:415–419
Sarkies N, Gregor Z, Forsey T, Darougar S (1986) Antibodies to herpes simplex virus type I in intraocular fluids of patients with acute retinal necrosis. Br J Ophthalmol 70:81–84
Schwartz GS, Harrison AR, Holland EJ (1998) Etiology of immune stromal (interstitial) keratitis. Cornea 17:278–281
Staats H, Oakes JE, Lausch RN (1991) Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets of asialo GM1+ cells. J Virol 65:6008
Tambasco FP, Cohen EJ, Nguyen LH, Rapuano CJ, Laibson PR (1999) Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 117:445–449
Timsit JC, Fortier B, Pontet F (1982) Value of the immunoenzyme method (ELISA) in determining serum and aqueous humor antiherpes immunoglobulin levels. J Fr Ophtalmol 5:669–674
Uchoa UBC, Rezende RA, Carrasco MA, Rapuano CJ, Laibson PR, Cohen EJ (2003) Long-term Acyclovir use to prevent recurrent ocular herpes simplex virus infection. Arch Ophthalmol 121:1702–1704
Van der Lelij A, Rothova A (1997) Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol 81:976–979
van Gelderen BE, Van der Lelij A, Treffers WF, van der Gaag R (2000) Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons. Br J Ophthalmol 84:1238–1243
Acknowledgements
This work was supported by Association Française des Amblyopes Unilatéraux, Société Française d'Ophtalmologi, Banque Française des Yeux, and Deutsche Forschungsgemeinschaft (Pl 150/14-1). We thank Pierre-Marie Preux, Department of Biostatistics, Limoges, for his kind assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robert, PY., Liekfeld, A., Metzner, S. et al. Specific antibody production in herpes keratitis: intraocular inflammation and corneal neovascularisation as predicting factors. Graefe's Arch Clin Exp Ophthalmo 244, 210–215 (2006). https://doi.org/10.1007/s00417-005-0014-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-005-0014-7